FEATURES OF CIRCULATION OF HEPATITIS C VIRUS IN KHABAROVSK REGION

Cover Page


Cite item

Abstract

Aim. Study the intensity of circulation of HCV in Khabarovsk Region and genetic variants of the virus circulating in the region. Materials and methods. 940 sera samples obtained from individuals with unestablished risk factors for HCV infection in polyclinic of the Far-Eastern Regional Centre for Prophylaxis and Control of AIDS (Khabarovsk) were studied. Individuals of the following age groups were included into the study: 1 - 4, 5 - 9,10 - 14,15 - 19,20 - 29, 30 - 39, 40 - 49, 50 - 59, older than 60 years; each group included approximately 100 individuals. Anti-HCV was determined in all the samples, HCV RNA was determined in samples positive for anti-HCV. Phylogenetic analysis with a time scale for the detected genovariants of HCV was carried out for reconstruction of the history of prevalence of HCV in Khabarovsk Region. Trees were constructed using BEAST vl.8.2 program by 2 genome sequences - core (1043 bp) and NS5B (389 bp). Results. The mean prevalence of anti-HCV among the examined individuals was 9.3% (87/940). The proportion of individuals with a current HCV-infection (presence of HCV RNA) was 4.2% (39/940). A sharp increase of HCV prevalence was observed beginning from the age group 20 - 29, where frequency of anti-HCV was 13.1% (13/99) that is 6 times higher compared with the previous age group of 15 - 19 (2,2%, p<0.01). The highest frequency of detection of HCV markers was observed in the age group 40 - 49 (20.8 and 9.4% for anti-HCV and HCV RNA, respectively). The frequency of detection of anti-HCV and HCV RNA in the 30-39 group was 20.2 and 8.9%, respectively, and among individuals older than 60-16.8 and 7.4%, respectively. Genotype lb was determined for 64.2% of HCV isolates, 28.3% of isolates belonged to genotype 3a, and 3 isolates were similar to genotype la, 2a and 2c members. Genotype lb was introduced into Khabarovsk Region around 55 - 65 years ago from Japan and the USA, around 15 years later - genotype 3a. Importation of novel HCV genotype 3a strains from Europe took place many times, these strains are present across the whole Russia. Conclusion. The data obtained have demonstrated high prevalence of HCV in the Khabarovsk Region, that has formed due to a prolonged circulation of the virus in the region.

About the authors

N. V. Soboleva

Chumakov Institute of Poliomyelitis and Viral Encephalitis

Author for correspondence.
Email: noemail@neicon.ru
Russian Federation

A. A. Karlsen

Russian Medical Academy of Continuous Professional Education, Mechnikov Research Institute of Vaccines and Sera

Email: noemail@neicon.ru
Russian Federation

O. V. Isaeva

Russian Medical Academy of Continuous Professional Education, Mechnikov Research Institute of Vaccines and Sera

Email: noemail@neicon.ru
Russian Federation

K. K. Kyuregyan

Russian Medical Academy of Continuous Professional Education, Mechnikov Research Institute of Vaccines and Sera

Email: noemail@neicon.ru
Russian Federation

O. E. Trotsenko

Khabarovsk Research Institute of Epidemiology and Microbiology

Email: noemail@neicon.ru
Russian Federation

M. I. Mikhaylov

Russian Medical Academy of Continuous Professional Education, Mechnikov Research Institute of Vaccines and Sera

Email: noemail@neicon.ru
Russian Federation

References

  1. Вирусные гепатиты в Российской Федерации. Под ред. В.И.Покровского, А.Б.Жебруна. СПб, ФБУН НИИЭМ им. Пастера, 2013.
  2. МукомоловС.Л.,ЛеваковаИ.А., Сулягина Л.Г., СинайскаяЕ.В., БолсунД.Д.,Иванова Н.В. Современная эпидемиология гепатита С в России. Эпидемиология и инфекционные болезни. 2012, 6: 21-25
  3. Пименов Н.Н., Чуланов В.П., Комарова С.В. и др. Гепатит С в России: эпидемиологическая характеристика и пути совершенствования диагностики и надзора. Эпидемиология и инфекционные болезни. 2012, 3: 4-10.
  4. Ракицкий Г.Ф., Плющенко В.Н., Дорожкина Л.И., Брылева И.Н., Песня С.В. О состоянии психиатрической и наркологической помощи населению края и мерах по ее совершенствованию. Здравоохранение Дальнего Востока. 2011, 4 (50): 25-34.
  5. Armstrong G.L., Wasley A., Simard Е.Р. et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann. Intern. Med. 2006, 144: 705-714.
  6. Durham D.P, Skrip L.A., Bruce R.D. et al. The impact of enhanced screening and treatment on hepatitis C in the United States. Clin. Infect. Dis. 2016, 62(3):298-304. doi: 10.1093/cid/ civ894. Epub. 2015 Nov 30.
  7. Global Burden of Disease Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J. Clin. Pharmacol. 2004, 44: 20-29.
  8. McGarry L.J., Pawar V.S., Panchmatia H.R. et al. Economic model ofabirth cohort screening program for hepatitis C virus. Hepatology. 2012, 55 (5): 1344-1355.
  9. Mohd Hanafiah K., Groeger J., Flaxman A.D., Wiersma S.T. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013,57 (4): 1333-1342.
  10. ShepardC.W., Finelli L., Alter M.J. Global epidemiology ofhepatitisC virus infection. Lancet Infect. Dis. 2005, 5: 558-567.
  11. Shapiro B., Rambaut A., Drummond A.J. Choosing appropriate substitution models for the phylogenetic analysis of protein-coding sequences. Mol. Biol. Evol. 2006, 23 (1): 7-9.
  12. Smith B.D., Morgan R.L., Beckett G.A. et al. Centers for Disease Control and Prevention (CDC). Recommendations for the identification of chronic hepatitis C virus infection among persons bom during 1945-1965. MMWR Recom. Rep. 2012, 61 (No. RJR-4): 1-32. Erratum in: MMWR Recom. Rep. 2012, 61: 886.
  13. Wasley A., Alter M.J. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis. 2000, 20: 1-16.

Copyright (c) 2017 Soboleva N.V., Karlsen A.A., Isaeva O.V., Kyuregyan K.K., Trotsenko O.E., Mikhaylov M.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies